JPR Royalty Sub LLC

BioCryst is a global biotech company with over three decades of experience in drug discovery, development, and commercialization. They are dedicated to developing novel medicines for complement-mediated and other rare diseases, aiming to restore a sense of freedom for patients. With a transparent and supportive culture, BioCryst empowers its employees to achieve beyond what they think is possible, while their community promise ensures that patients worldwide can take part in the everyday activities they enjoy.

Driven by a commitment to improving the lives of patients, BioCryst listens to and understands their needs, working collaboratively with advocacy organizations to get the right treatments into the hands of those who need them most. Through a blend of traditional biology, medicinal chemistry, and advanced technologies, BioCryst focuses on breaking new ground in complement-mediated and other rare diseases, delivering first-in-class or best-in-class oral small-molecule and protein therapeutics to patients.

Generated from the website